Literature DB >> 11831695

Characterization of a functional hepatocyte nuclear factor 3 binding site in the hepatitis B virus nucleocapsid promoter.

J L Johnson1, A K Raney, A McLachlan.   

Abstract

Mutational analysis of the hepatitis B virus (HBV) nucleocapsid promoter previously demonstrated that a regulatory sequence element (CpE) located between -72 and -56 modulated the level of transcription from this promoter in differentiated, but not dedifferentiated, hepatoma cell lines. Using gel retardation analysis, it was shown that the formation of a complex between the nucleocapsid CpE promoter sequence and the DNA-binding proteins present in the differentiated hepatoma cell line Huh7 was inhibited from forming in the presence of either the large surface antigen promoter hepatocyte nuclear factor 3 (HNF3) binding site or an HNF3beta-specific antiserum. Purified recombinant HNF3alpha transcription factor was also shown to bind specifically to the CpE promoter sequence by gel retardation and DNase I footprinting analysis. In addition, DNase I footprinting analysis supported the suggestion that the nucleocapsid promoter region contains a second HNF3 binding site located between -112 and -86. The nucleocapsid promoter CpE regulatory element was shown to be a functional HNF3 binding site capable of mediating HNF3beta-specific transcriptional transactivation in transient transfection analysis. These results suggest that the liver-enriched family of HNF3 transcription factors is involved in regulating the level of expression from the nucleocapsid promoter, in addition to the large surface antigen promoter, and is likely to be important in the coordinate regulation of HBV transcription during infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 11831695     DOI: 10.1006/viro.1995.1138

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4.

Authors:  C K Lai; L P Ting
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II.

Authors:  K Ueda; Y Wei; D Ganem
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

Authors:  H Ishida; K Ueda; K Ohkawa; Y Kanazawa; A Hosui; F Nakanishi; E Mita; A Kasahara; Y Sasaki; M Hori; N Hayashi
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Hepatocyte nuclear factor 3beta inhibits hepatitis B virus replication in vivo.

Authors:  Krista E Banks; Aimee L Anderson; Hong Tang; Douglas E Hughes; Robert H Costa; Alan McLachlan
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta.

Authors:  Hong Tang; Alan McLachlan
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 6.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

7.  Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha.

Authors:  Christophe Ramière; Caroline Scholtès; Olivier Diaz; Vinca Icard; Laure Perrin-Cocon; Mary-Anne Trabaud; Vincent Lotteau; Patrice André
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

8.  JFC1 is transcriptionally activated by nuclear factor-kappaB and up-regulated by tumour necrosis factor alpha in prostate carcinoma cells.

Authors:  Sergio D Catz; Bernard M Babior; Jennifer L Johnson
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

9.  Avian and Mammalian hepadnaviruses have distinct transcription factor requirements for viral replication.

Authors:  Hong Tang; Alan McLachlan
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Transcriptional and posttranscriptional control of hepatitis B virus gene expression.

Authors:  Susan L Uprichard; Stefan F Wieland; Alana Althage; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.